OpenURL Connection Search

Select item for more details and to access through your institution.

Tailoring second-line or above therapy for patients with advanced or metastatic gastric cancer: A multicenter real-world study.
Published in:
Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1043217
By:
- Caiyun Nie;
- Weifeng Xu;
- Huifang Lv;
- Xiaohui Gao;
- Guofeng Li;
- Beibei Chen;
- Jianzheng Wang;
- Yingjun Liu;
- Jing Zhao;
- Yunduan He;
- Saiqi Wang;
- Xiaobing Chen
Publication type:
Article
Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer.
Published in:
BMC Geriatrics, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12877-022-03637-9
By:
- Chen, Beibei;
- Zhao, Huichen;
- Huang, Jinxi;
- Lv, Huifang;
- Xu, Weifeng;
- Nie, Caiyun;
- Wang, Jianzheng;
- Zhao, Jing;
- He, Yunduan;
- Wang, Saiqi;
- Chen, Xiaobing
Publication type:
Article
Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer.
Published in:
BMC Geriatrics, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12877-022-03637-9
By:
- Chen, Beibei;
- Zhao, Huichen;
- Huang, Jinxi;
- Lv, Huifang;
- Xu, Weifeng;
- Nie, Caiyun;
- Wang, Jianzheng;
- Zhao, Jing;
- He, Yunduan;
- Wang, Saiqi;
- Chen, Xiaobing
Publication type:
Article
Identification of neutrophil extracellular trap-driven gastric cancer heterogeneity and C5AR1 as a therapeutic target.
Published in:
Acta Biochimica et Biophysica Sinica, 2024, v. 56, n. 4, p. 538, doi. 10.3724/abbs.2023290
By:
- Jing Zhao;
- Xiangyu Li;
- Liming Li;
- Beibei Chen;
- Weifeng Xu;
- Yunduan He;
- Xiaobing Chen
Publication type:
Article
Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1010554
By:
- Weifeng Xu;
- Caiyun Nie;
- Huifang Lv;
- BeiBei Chen;
- Jianzheng Wang;
- Saiqi Wang;
- Jing Zhao;
- Yunduan He;
- Xiaobing Chen
Publication type:
Article
Individual Irinotecan Therapy Under the Guidance of Pre-Treated UGT1A1 * 6 Genotyping in Gastric Cancer.
Published in:
Technology in Cancer Research & Treatment, 2024, p. 1, doi. 10.1177/15330338241236658
By:
- Lv, Huifang;
- Nie, Caiyun;
- He, Yunduan;
- Chen, Beibei;
- Liu, Yingjun;
- Zhang, Junling;
- Chen, Xiaobing
Publication type:
Article
High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study.
Published in:
Technology in Cancer Research & Treatment, 2023, p. 1, doi. 10.1177/15330338221150561
By:
- Nie, Caiyun;
- Lv, Huifang;
- Chen, Beibei;
- Xu, Weifeng;
- Wang, Jianzheng;
- Wang, Saiqi;
- Liu, Yingjun;
- He, Yunduan;
- Zhao, Jing;
- Chen, Xiaobing
Publication type:
Article
Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid Tumors.
Published in:
Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/4233782
By:
- Wang, Jianzheng;
- Zhang, Baiwen;
- Cheng, Xiaojiao;
- Li, Qingli;
- Lv, Huifang;
- Nie, Caiyun;
- Chen, Beibei;
- Xu, Weifeng;
- Zhao, Jing;
- He, Yunduan;
- Tu, Shuiping;
- Chen, Xiaobing
Publication type:
Article
Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world study.
Published in:
BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11735-z
By:
- Nie, Caiyun;
- Xu, Weifeng;
- Guo, Yanwei;
- Gao, Xiaohui;
- Lv, Huifang;
- Chen, Beibei;
- Wang, Jianzheng;
- Liu, Yingjun;
- Zhao, Jing;
- Wang, Saiqi;
- He, Yunduan;
- Chen, Xiaobing
Publication type:
Article
An Exploration of Trifluridine/Tipiracil Monotherapy and in Combination With Bevacizumab or Immune Checkpoint Inhibitors for Patients With Metastatic Colorectal Cancer: A Real-World Study.
Published in:
Clinical Colorectal Cancer, 2023, v. 22, n. 1, p. 76, doi. 10.1016/j.clcc.2022.11.005
By:
- Caiyun Nie;
- Weifeng Xu;
- Beibei Chen;
- Huifang Lv;
- Jianzheng Wang;
- Yingjun Liu;
- Yunduan He;
- Saiqi Wang;
- Jing Zhao;
- Xiaobing Chen
Publication type:
Article
In era of immunotherapy: the value of trastuzumab beyond progression in patients with trastuzumab-resistant HER2-positive advanced or metastatic gastric cancer.
Published in:
Therapeutic Advances in Gastroenterology, 2024, p. 1, doi. 10.1177/17562848241245455
By:
- Wang, Hui;
- Nie, Caiyun;
- Xu, Weifeng;
- Li, Jing;
- Gou, He;
- Lv, Huifang;
- Chen, Beibei;
- Wang, Jianzheng;
- Liu, Yingjun;
- He, Yunduan;
- Zhao, Jing;
- Chen, Xiaobing
Publication type:
Article
Microsatellite stable metastatic colorectal cancer without liver metastasis may be preferred population for regorafenib or fruquintinib plus sintilimab as third-line or above therapy: A real-world study.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.917353
By:
- Caiyun Nie;
- Huifang Lv;
- Beibei Chen;
- Weifeng Xu;
- Jianzheng Wang;
- Yingjun Liu;
- Saiqi Wang;
- Jing Zhao;
- Yunduan He;
- Xiaobing Chen
Publication type:
Article
Clinical Study of Anlotinib as Third-Line or Above Therapy in Patients With Advanced or Metastatic Gastric Cancer: A Multicenter Retrospective Study.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.885350
By:
- Caiyun Nie;
- Yunduan He;
- Huifang Lv;
- Ming Gao;
- Xiaohui Gao;
- Beibei Chen;
- Weifeng Xu;
- Jianzheng Wang;
- Yingjun Liu;
- Jing Zhao;
- Xiaobing Chen
Publication type:
Article
The Efficacy and Safety of Sintilimab Combined With Nab-Paclitaxel as a Second-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.924149
By:
- Wang, Jianzheng;
- He, Yunduan;
- Zhang, Baiwen;
- Lv, Huifang;
- Nie, Caiyun;
- Chen, Beibei;
- Xu, Weifeng;
- Zhao, Jing;
- Cheng, Xiaojiao;
- Li, Qingli;
- Tu, Shuiping;
- Chen, Xiaobing
Publication type:
Article

Found: 14